investing in life science innovation  tvm capital life science venture capital skip to primary navigation skip to content skip to footer tvm capital life science venture capitalinvesting in life science innovationmain navigation investing in life science innovation tvm capital life science is a group of independent investment advisories and fund managers for venture capital funds investing into innovative biotech pharmaceutical and medtech companies in europe canada the usa and asia with teams based in munich and montreal learn more main contentacer therapeutics and opexa therapeutics sign merger agreementjuly  proteon therapeutics announces  million private placementjune  centogene raises a eur  million series a financing to fuel innovation and to accelerate growth into personalized medicinejune   footerabout us we are creating sustainable value – for patients the pharmaceutical industry and our investors since  tvm capital life science has invested in more than  life science companies in europe canada and the united states currently managing in excess of € million from more than  investors read more our team tvm capital life science operates with an integrated team from its offices in montreal and munich our mission is to invest in the development of exciting life science products and the growth of substantial companies in the field that are or aspire to be innovative leaders in their market segment read more offices tvm capital gmbh munich germany tvm life science management gmbh munich germany tvm life science management inc montreal westmount canada tvm capital group tvm capital healthcare tvm capital life science tvm life science ventures vi lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors tvm life science ventures vi lp check out list of companies and businesses related to tvm life science ventures vi lp find out tvm life science ventures vi lp address and contact details view other people related to tvm life science ventures vi lp  coworkers colleagues companions etc address co tvm capital group ottostrasse  munich  germany companies related to tvm life science ventures vi lp cikcompany namepositioncompany addressproteon therapeutics inc west street waltham concert pharmaceuticals inc hayden avenue suite  lexington  tvm life science ventures vi lp on the web persons related to tvm life science ventures vi lp  proteon therapeutics incnamepositioncityllp abingworth owner londonhubert birnerdirector northbrookhubert birnerdirector munichgaren g bohlindirector garen g bohlinwalthamoleary brendanneedhamoleary brendanwalthamsteven keith burkesvp and chief medical officer walthamscott a canutedirector indianapolisgottlieb danielwalthamlowe davidpalo altoprofis deanwalthammanagement co deerfieldnew yorkdeerfield mgmt iii lpnew yorkdeerfield mgmt iii lpnew yorkdeerfield mgmt lpnew yorkdeerfield private design fund iii lpnew yorkdeerfield special situations fund lpnew yorkdeerfield special situations fund lpnew yorkdeerfield special situations international master fund lpnew yorkkobyzev dmitrywalthamgeorge arthur eldridgesr vp cfo treasr asst secy walthamfranano folathefranano fwalthamstefan fischermunichstefan fischermunichjames e flynn owner new yorkjohn gordon freunddirector palo altojohn gordon freundpalo altojohn gordon freunddirector palo altoeldridge georgewalthamalexandra gollmunichdaniel philip gottliebvp corporate development walthamphelps gregorywalthamtimothy hainesdirector londonpaul j hastingsdirector birner hubertbostonbirner hubertwalthamfreund johnwalthamyasunori kanekopalo altostuart a kingsleydirector marlboroughdmitry kobyzevdirector moscowmatthew paul kowalskyvp legal and secretary walthamtimothy p noyespresident and ceo walthambrendan olearydirector needhambrendan olearydirector needhaminternational sa pharmstandard owner luxembourggregory d phelpsdirector cambridgegregory d phelpswalthamprism venture partners va lpneedhamprism venture partners v l pneedhamjoint stock co pharmstandard publicdolgoprudnyhelmut schuhslermunichhelmut schuhslermunichskyline venture management iv llcpalo altoskyline venture partners qualified purchaser fund iv l p owner palo altohoffman stephenwalthamburke stevenwalthamst peter stevenbostonhaines timwalthamnoyes timothywalthamfoley toddbostonfoley toddwalthame scott tonersenior vp of marketing walthamtvm life science ventures vi gmbh  co kg owner munichpersons related to tvm life science ventures vi lp  concert pharmaceuticals incnamepositioncityadage capital advisors llcbostonadage capital partners gp llcbostonadage capital partners lp owner bostonnoubar afeyancambridgerichard aldrichdirector bostonrichard aldrichdirector lexingtonrobert atchinsonbostonthomas g auchinclossdirector cambridgethomas g auchinclossdirector lexingtonronald w barrettdirector santa clararonald w barrettlexingtonhubert birnermunichbrookside capital investors l pbostonbrookside capital management llc owner bostonbrookside capital partners fund lpbostonjames v cassellachief development officer palo altojames v cassellalexingtonphilippe o chambonnew yorkd ryan dawschief financial officer lexingtonjeani delagardellesan mateostefan fischermunichmeghan fitzgeralddirector new havenflagship ventures fund  l p owner cambridgeflagship ventures general partner llccambridgejohn gordon freunddirector palo altojohn gordon freundpalo altojohn gordon freundpalo altoplc glaxosmithklinebrentford middlesexplc glaxosmithkline brentford middlesexalexandra gollmunichalexandra gollmunichxiia limited partnership greylockmenlo parkgreylock xii gp llc owner menlo parkxii limited partnership greylockmenlo parkphillip grossbostonlynette herschageneral counsel lexingtonronald huntnew yorkpeter barton huttdirector irvinepeter barton huttdirector lexingtonwilfred e jaegerdirector portola valleywilfred e jaegerportola valleyyasunori kanekopalo altoyasunori kanekopalo altoedwin m kania jrcambridgevijay k lathisan mateoryan lynchpfo pao lexingtonpauline mcgowanvp finance lexingtonnew leaf venture management i llcnew yorknew leaf venture management i lpnew yorknew leaf ventures i lp owner new yorkjames niedelnew yorkaxel polackmunichaxel polackmunichqvt associates gp llc owner new yorkqvt fund lpgeorge town grand caymanqvt fund v lpnew yorkliam ratcliffenew yorkhelmut schuhslerdirector munichhelmut schuhslermunichrobert silvermansenior vp general counsel lexingtonskyline venture management iv llcpalo altoskyline venture management iv llcpalo altoskyline venture partners qualified purchaser fund iv l ppalo altoskyline venture partners qualified purchaser fund iv l p owner palo altonancy stuartchief operating officer lexingtonthree arch associates iii lpportola valleythree arch associates iv lpportola valleythree arch management iii llcportola valleythree arch management iii llcdirector portola valleythree arch management iv llcdirector portola valleythree arch partners iii lpportola valleythree arch partners iii lpportola valleythree arch partners iv lpportola valleyroger d tungchief executive officer lexingtontvm life science ventures vi gmbh  co kgdirector munichheek christi vandirector palo altomark a wanportola valleymark a wanportola valleywendall wierengadirector lexingtonwendall d wierengadirector san diego tvm life science ventures vi lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active tvm life science ventures vi lp • cayman island a how do i update this listing tvm life science ventures vi is based out of cayman island whalewisdom has at least  dg filings in our database for tvm life science ventures vi summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from tvm life science ventures vi lp enter your email address below and choose submit your email cancel contact info tvm life science ventures vi lp po box  ugland house cayman island a     business phone     recent sec filings a filed on   filed on  sc d filed on  sc d filed on   filed on   filed on   filed on   filed on  current dg holdings stock sector shares held market value rank source source date proteon theraptc prto health care    d  albireo pharma inc albo health care    d  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free investment and shareholders agreement  shareholder agreement  free search  you are here agreements  shareholder agreement  investment and shareholders agreement search documents  browse documents site search agreements  contracts document title entire documentoptional governing lawoptional allalabamaalaskaarizonaarkansascaliforniacoloradoconnecticutdelawareflorida georgiahawaiiidahoillinoisindianaiowakansaskentuckylouisianamainemaryland massachusettsmichiganminnesotamississippimissourimontananebraskanevada new hampshirenew jerseynew mexiconew yorknorth carolinanorth dakotaohiooklahoma oregonpennsylvaniarhode islandsouth carolinasouth dakotatennesseetexasutah vermontvirginiawashingtonwest virginiawisconsinwyoming try our advanced search  clauses search contract clauses  browse contract clause library investment and shareholders agreement shareholder agreement you are currently viewing  this shareholder agreement involves life sciences opportunities fund institutional ii lp  life sciences opportunities fund ii lp  mc corporate services ltd  spepharm holding bv  tvm life science ventures vi gmbh co  tvm life science ventures vi lp  tvm lp realdealdocs™ contains millions of easily searchable legal documents and clauses from top law firms search for free  click here   title investment and shareholders agreement date  industry biotechnology and drugs     sector healthcare preview edit  save related documents  of the top  law firms use our products every day   exhibit  investment and shareholders’ agreement spepharm holding bv by and among    tvm life science ventures vi lp  co mc corporate services ltd po box  ugland house south church street grand cayman cayman islands  hereinafter referred to as “ tvm lp ”     tvm life science ventures vi gmbh  co kg  maximilianstr  c d munich germany  hereinafter referred to as “ tvm kg ”     life sciences opportunities fund institutional ii lp   east  th street  th floor new york ny  usa  hereinafter referred to as “ lsofi ”     life sciences opportunities fund ii lp   east  th street  th floor new york ny  usa  hereinafter referred to as “ lsof ”     arcade sarl   rue des mathurins  paris france  hereinafter referred to as “ arcade ”   tvm lp tvm kg lsofi lsof and arcade hereinafter referred to as “ investors ”  as well as    valera pharmaceuticals inc   clarke drive cranbury nj usa   hereinafter referred to as “ valera ”   valera and the investors as well as other future shareholders of spepharm holding bv which may accede to this shareholders agreement hereinafter referred to as “ shareholders ”  and    jeanfrançois labbé   allée des bocages  le vésinet france  hereinafter referred to as “ jflab ”  as well as upon its incorporation and accession hereto    spepharm holding bv  co mr wim van bree heinsiuslaan   jg amersfoort the netherlands     hereinafter referred to as the “ company ”  all of the above stated parties — as well as any third party that accedes to this investment and shareholders’ agreement “ this agreement ” in the future as of such accession — hereinafter the “ parties ”    recitals sec  foundation of spepharm and loan commitment by lsofi and lsof sec  first capital increase sec  second capital increase sec  general obligations with regard to capital increases  syndication sec  default on investment obligation sec  valera’s covenant to obtain shire waiverlicence sec  other covenants sec  intellectual property rights sec  transfer of shares  notification sec  rights of first refusal sec  tagalong rights sec  dragalong rights sec  restrictions of transfer sec  share transfers and share issuance under accession to this agreement sec  transfers to affiliated companies and funds sec  stock incentive scheme sec  supervisory board sec  information sec  refinancing by kfw sec  effective date  succession of rights sec  delivery addresses and authorised recipients sec  amendments to and cancellation of this agreement sec  miscellaneous    recitals valera and the investors intend to jointly create incorporate and finance a dutch bv under the name of spepharm holding bv with its registered office in amsterdam to serve as the parent company of a european specialty pharmaceutical group of companies with the vision to become one of the leading suppliers of specialty urology and endocrinology products to the european market place for this purpose and in order to regulate the legal relationship among themselves as future shareholders of the company valera and the investors enter into the following agreement which they expect the company to accede to in due course sec  foundation of spepharm and loan commitment by lsofi and lsof    immediately after signing this agreement the investors and valera shall set up a new bv under dutch law to be named spepharm holding bv the “ company ” and shall provide all information necessary to apply to the ministry of justice for its consent to the company’s incorporation the investors and valera shall be entitled and obliged to subscribe for the company’s initial shares and make payments in the following amounts with the term “cost” referring to sec   below                           payment in eur     shares   nominal   premium   total tvm lp           cost     cost                   tvm kg           cost     cost                   lsofi           cost     cost                   lsof           cost     cost                   arcade           cost     cost                   valera         —    the payments of the nominal amounts shall be effected to the company’s bank account and the payments of the premium shall be effected to a notary’s third party account in each case immediately upon the consent to the company’s incorporation by the ministry of justice having been granted without delay upon the receipt of all payments set forth above on the company’s bank account and on the notary’s third party account respectively the notarial deed for incorporation of the company shall be executed    the shareholders shall adopt articles of association for the company in the form set out in appendix     jflab shall become the company’s initial director immediately after the foundation deed of the company has been executed jflab shall offer to the company the conclusion of a service agreement at terms and conditions as set forth in appendix     the shareholders shall appoint messrs david tierney james gale hubert birner and bernd seibel as members of the company’s initial supervisory board the parties shall to the extent legally permissible and respecting the independence of the supervisory board and its members use their best efforts and all the influence they have to the effect that the supervisory board adopts the rules of procedure for the management as set forth in appendix  immediately upon their appointment       lsofi and lsof undertake to grant to the company immediately upon the company’s incorporation short term loans in the amount of eur  and eur  respectively at the terms and conditions set forth in the draft loan agreement as attached hereto as appendix   sec  first capital increase    if the company requires additional funds it shall inform the shareholders accordingly in writing each investor shall within six weeks as of receipt of such information notify the company and the shareholders whether such investor supports the additional funding if investors who hold together a qualified investor majority as defined in sec   below notify the company and the shareholders within such six weeks period of their support of the additional funding the company shall without delay call for a written shareholders resolution of an increase of the company’s share capital from eur  by up to eur  to up to eur  by issuing new shares in the company the “ first capital increase ” to valera and the investors all shareholders shall participate in and vote in favour of the resolution on the first capital increase waiving all requirements as to the form and time period for calling such shareholders resolution    the investors shall then each be entitled and obliged to subscribe for the company’s new             shares from the first capital increase and make payments in the following amounts with the term “cost” referring to sec   below                           payment in eur     shares   nominal   premium   total tvm lp           cost    – cost                   tvm kg           cost    – cost                   lsofi           cost    – cost                   lsof           cost    – cost                   arcade         —    provided that one or more third party investors or any of the investors agree to subscribe for new shares from the first capital increase and make payments in the following amounts                                          payment in eur     shares   nominal   premium   total third party investors                  — cost    – cost the payments set forth above in this sec   shall be effected within one week after the resolution on the first capital increase has been taken to a notary’s third party account instructing the notary to pay these amounts to the company upon the execution of the notarial deed on the first capital increase and issuance of the new shares as set forth in the above table    immediately upon payment of all of the above stated amounts but in any event after the lapse of four weeks as of the shareholders’ resolution on the first capital increase the company shall inform valera on the extent to which the first capital increase has been subscribed and paid pursuant to sec   and shall offer to issue to valera  of the entire new shares from the first capital increase ie the aggregate amount of the new shares subscribed and paid for pursuant to sec   plus the shares to be allotted to valera pursuant to this sec   so that following such issuance valera would own  or – in case of sec   –  of the outstanding shares of the company at a price that equals such shares’ nominal amount valera shall subscribe and pay for those shares within one week as of receipt of such offer or the offer shall lapse valera’s payment shall be made to the same notary’s third party account as used for the purpose of sec   equally instructing the notary to pay these amounts to the company upon the execution of the notarial deed on the first capital increase and issuance of the respective new shares to valera    in addition to the payment set forth to be made to the company by arcade in the table in sec   arcade hereby commits towards the shareholders but without obliging itself towards the company and provided that the company has not filed for insolvency or has become obliged to file for insolvency prior to such payment to make an additional payment of eur  minus cost see sec   below into the company’s capital reserves at the latest immediately prior to any of the following events i a trade sale as defined in sec   below ii an initial public offering of shares of the company iii the liquidation of the company but not in the context of an insolvency and iv any transfer of any shares by arcade except for share transfers under sec   if the acquirer assumes this payment obligation nothing in this sec   shall be interpreted to grant to the company any right or claim to the additional payment by arcade sec  second capital increase    if after implementation of the first capital increase the company requires additional funds it shall inform the shareholders accordingly in writing each investor shall within six weeks as of receipt of such information notify the company and the shareholders whether such investor supports the additional funding if investors who hold together a qualified investor majority as defined in sec   below notify the company and the shareholders within such six weeks period of their support of the additional funding the company shall without delay call for a written shareholders resolution of a further increase of the company’s share capital by up to eur  by issuing new shares in the company the “ second capital increase ” to valera and the investors all shareholders shall participate in and vote in favour of the resolution on the second capital increase waiving all requirements as to the form and time period for calling such shareholders resolution    the investors shall then each be entitled and obliged to subscribe for the company’s new shares from the second capital increase and make payments in the following amounts                              payment in eur     shares   nominal   premium   total tvm lp                               tvm kg                               lsofi                               lsof                               arcade         —                      third party investors             such payments shall be effected within one week after the resolution on the second capital increase has been taken to a notary’s third party account instructing the notary to pay these amounts to the company upon the execution of the notarial deed on the second capital increase and issuance of the new shares as set forth in the above table    immediately upon payment of all of the above stated amounts but in any event after the lapse of four weeks as of the shareholders’ resolution on the second capital increase the company shall inform valera on the extent to which the second capital increase has been subscribed and paid pursuant to sec   and shall offer to issue to valera  or – in case of sec   –  of the entire new shares from the second capital increase ie the aggregate amount of the new shares subscribed and paid for pursuant to sec   plus the shares to be allotted to valera pursuant to this sec   so that following such issuance valera would own  or – in case of sec   –  of the outstanding shares of the company provided that valera has fully subscribed to the shares offered to valera pursuant to sec   at a price that equals such shares’ nominal amount valera shall subscribe and pay for those shares within one week as of receipt of such offer or the offer shall lapse valera’s payment shall be made to the same notary’s third party account as used for the purpose of sec   equally instructing the notary to pay these amounts to the company upon the execution of the notarial deed on the second capital increase and issuance of the respective new shares to valera    in addition to the payment set forth to be made to the company by arcade in the table in sec   arcade hereby commits towards the shareholders but without obliging itself towards the company and provided that the company has not filed for insolvency or has become obliged to file for insolvency prior to such payment to make an additional payment of eur  on top of the additional payment under sec   above into the company’s capital reserves at the latest immediately prior to any of the following events i a trade sale as defined in sec   below ii an initial public offering of shares of the company iii the liquidation of the company but not in the context of an insolvency and iv any transfer of any shares by arcade except for share transfers under sec   if the acquirer assumes this payment obligation nothing in this sec   shall be interpreted to grant to the company any right or claim to the additional payment by arcade sec  general obligations with regard to capital increases  syndication    to the extent necessary to implement secs  and  the shareholders shall waive their statutory subscription rights for the first and second capital increase       the parties shall make any and all statements and undertake any and all actions necessary or appropriate including the cooperation with the execution of any relevant notarial deeds to implement the aforesaid resolutions set out in secs  to  as soon as reasonably practicable    each of the investors listed on the cover page of this agreement shall be entitled to transfer and assign its rights and obligations to subscribe and pay for shares from the first and second capital increase to a third party provided that such third party i meets the approval of shareholders who hold together a majority of the shares held by all shareholders at the time of the approval and ii accedes to this agreement as an investor by a syndication and accession agreement as set forth in draft form as appendix a hereto which shall be accepted on behalf of all parties by the respective investor who transfers and assigns its rights and obligations the same requirements shall apply to the third party investor or third party investors envisaged in secs  and  to invest in the first and second capital increase except that in such case such third party investor shall accede to this agreement as an investor by an accession agreement as set forth in draft form as appendix b  which shall be accepted on behalf of all parties by any of the investors sec  default on investment obligation    if an investor fails i to subscribe for shares from the first or second capital increase or ii to make any of the payments under sec   and   in each case within the time period provided for with regard to such subscription or payment in the respective sections above plus a grace period of one additional week “ default ” such investor’s right to acquire shares from the respective first or second capital increase shall lapse in addition such investor the “ defaulting investor ” shall be obliged to transfer  of the shares held by such investor at that time to the other shareholders who shall be entitled to acquire such shares pro rata to their shareholdings for an aggregate consideration of eur  such amount to be pro rated among the shareholders receiving such transferred shares the share transfer shall be implemented without delay upon the lapse of the respective applicable time period plus the grace period of one week and the defaulting investor shall in particular provide all cooperation needed for the execution of the notarial deed of the share transfer secs  –  of this agreement shall not apply to such share transfer the company shall immediately inform all shareholders of such lapse of time and failure to subscribe or make payments    each investor hereby assigns subject to the condition precedent that he commits a default all of the relevant claims as defined hereinafter to all other shareholders at the time of default pro rata to their shareholdings at the time of default the relevant claims are  of all claims of the defaulting investor for dividends liquidation proceeds trade sale proceeds and redemption compensation with respect to all of the shares held by him at the time of default provided however that such claims arise or become payable in the time period between the default and the share transfer pursuant to sec   sec  valera’s covenant to obtain shire waiverlicence    valera hereby undertakes to obtain from shire us inc a license to the development data for the development manufacture use supply and sale of the licensed product in ireland each capitalised term as defined in the termination agreement license back and option dated  december  between hydro med sciences inc nka valera pharmaceuticals inc and shire us inc    if valera fails to obtain from shire such license by the lapse of six months as of the date of incorporation of the company valera shall transfer to the company without consideration such number of valera’s shares which represent  of the entire outstanding shares of the company at that time all parties shall in such event without delay upon the lapse of six        months after the incorporation of the company take all steps measures and resolutions necessary to implement such share transfer including – but not limited to – the shareholders resolution on the company’s acquisition of such shares and the company’s consent to such share transfer secs  –  shall not apply to such share transfer sec  other covenants    valera and the investors shall ensure that immediately upon the company’s incorporation the company will accede to this agreement by signing it    valera hereby offers to the company or any of its subsidiaries the conclusion of the licence and distribution agreement set out in appendix   and all parties shall ensure that the company or its appropriate subsidiary without delay accepts such offer and enters into said distribution and licence agreement upon the company’s or the appropriate subsidiary’s incorporation    it is the parties’ joint intention that the company sets up subsidiaries and a structure as set out in appendix  as amended from time to time by the company’s management with the approval of the company’s supervisory board the parties shall make any and all statements and undertake any and all actions necessary or appropriate to implement the aforesaid structure as soon as reasonably practicable provided however that no shareholder shall be obliged under this sec  to accept or enter into any financial obligations other than expressly provided for in this agreement the parties agree to procure that the articles of association or similar instruments of any future subsidiaries of the company will be established in such a manner that they will provide that prior approval of the respective subsidiary’s shareholders meeting shall be required for those resolutions or actions by such subsidiary’s management for which if such resolution or action was to be taken by the management of the company the management would require the consent of the company’s supervisory board thus ensuring that any such resolution or action ultimately requires the consent of the supervisory board of the company    all parties shall ensure that the company without delay upon its incorporation issues the management rights letter attached in draft form as appendix  hereto to tvm lp as well as to tvm kg by signing and acceding to this agreement the company undertakes to issue such management right letters without delay sec  intellectual property rights    the parties agree that jflab does not have any rights in or relating to intellectual property rights including without limitation any inventions patents copyrights and other industrial property rights especially with a view to software and related materials or rights for remuneration hereinafter collectively referred to as the “ ip rights ” in the field of speciality urology and endocrinology products the “ field ” for the avoidance of doubt jflab hereby offers to transfer to the company or the appropriate subsidiary to the extent legally possible any and all ip rights owned by him in the field without any additional compensation where such transfer is not possible for any legal reasons jflab herewith offers to grant to the company or the appropriate subsidiary an exclusive and irrevocable licence to use such ip rights for all currently known uses without any fee or other consideration being payable the offered grant of licence is as broad as legally possible and shall specifically without limitation be unlimited in respect of duration territorial scope and scope of the rights concerned exclusive transferable and shall include the right to modify the ip rights and to grant sublicences to third parties the licence shall also include the permanent or temporary reproduction of the work results by any means and in any form in part or in whole the loading displaying running transmission or storage of the work results the translation        adaptation arrangement and any other alteration of the work results and the reproduction of the results thereof without prejudice to the rights of the person who alters the work results any form of distribution to the public including the rental of the original work results or of copies thereof and the right to make available to the public the work results by any means    where the above transfer of rights and the grant of licences requires any further deeds acts or declarations jflab agrees to give and make any such deeds acts and declarations forthwith any costs accruing in this context shall be borne by the company or the appropriate subsidiary    at the request of the company or the appropriate subsidiary jflab shall demonstrate and explain all ip rights knowhow and any knowledge or work results in the field to an expert named by the company or the appropriate subsidiary and answer all questions such expert may have jflab shall make available to the company or the appropriate subsidiary all of his documentation on ip rights knowhow and any knowledge or work results in the field sec  transfer of shares  notification    in the event that a shareholder intends to transfer all or part of his shares in the company to any third person including other shareholders with or without consideration or to enter into any commercially equivalent transaction the “ selling shareholder ” the selling shareholder shall be obliged to notify the other shareholders of such intent in writing the “ notification ” with a copy to the chairman of the company’s supervisory board    the notification of the selling shareholder shall contain the following information   a   name  firm name and address  registered office of the selling shareholder     b   name  firm name and address  registered office of the prospective purchaser     c   description of business of the prospective purchaser     d   purchase price or other consideration for the proposed transfer if any     e   due date for payment of the purchase price and  or other consideration if any     f   number of shares to be transferred     g   representations and warranties as well as indemnities to be given and covenants to be assumed by each party to the proposed transfer    if however the selling shareholder intends to transfer shares for consideration other than cash the selling shareholder shall for the purpose of the right of first refusal under sec  indicate in the notification the value of any noncash consideration in cash according to the consideration’s fair market value in the event that another shareholder has reasonable doubt as to the accuracy of the consideration’s value such shareholder the “ objecting shareholder ” shall inform the selling shareholder accordingly in writing within two weeks as of the receipt of the notification indicating the value which the objecting shareholder believes to be accurate with a copy of such information to all other shareholders if the objecting shareholder and the selling shareholder do not agree within a period of one week on the value of the noncash consideration or on an expert to ultimately determine the noncash consideration’s fair market value such value shall be ultimately determined by an auditor nominated by the chairman of the dutch institute for chartered accountants  nederlands instituut voor register accountants – nivra  the agreed expert or auditor nominated by nivra hereinafter the “ expert ” such determination by the expert shall be finally binding for the purpose of the right of first refusal under sec  the selling shareholder shall notify in writing all other shareholders of the so determined fair market value of the noncash consideration immediately upon its determination with a copy to the chairman of the company’s supervisory board and the notification shall be deemed accordingly amended with regard to the purchase price  consideration and received by the other shareholders only        upon receipt of the notification on the noncash consideration’s fair market value as determined by the expert the cost of the expert’s determination of the noncash consideration’s fair market value shall be borne by the objecting shareholder if the determined value is closer to the selling shareholder’s indication of value in the notification and by the selling shareholder if the determined value is closer to the objecting shareholder’s indication of value sec  rights of first refusal    in the event that a shareholder intends to sell his present or future shares in the company for consideration purchase  swap  contribution against shareholder’s rights etc the shareholders other than the selling shareholder shall have a right of first refusal as set forth in the following provisions to acquire the shares which the selling shareholder intends to sell at the terms and conditions set forth in the notification pursuant to sec   and     within  days of receipt of the notification each shareholder other than the selling shareholder who wishes to exercise a right of first refusal shall state in writing to the selling shareholder the maximum number of shares the “ acquisition limit ” he is willing to acquire at the terms and conditions set forth in the notification pursuant to sec   and  hereinafter the “ purchase statement ” with a copy to the chairman of the company’s supervisory board such statement shall be binding in accordance with sec    and  below    if the aggregate number of shares that all shareholders other than the selling shareholder have stated to be willing to acquire within the aforesaid dayperiod falls short of the aggregate number of shares which the selling shareholder intends to sell pursuant to the notification the selling shareholder shall inform all other shareholders accordingly and no right of first refusal shall apply at all the selling shareholder subject to the shareholders’ tagalong rights pursuant to sec  and the provisions of sec  shall be entitled to sell his shares but only in strict accordance with the notification within two months upon the lapse of the aforesaid daysperiod the purchase agre shareholder agreement shareholder contracts  free legal documents page  of   you are here agreements  shareholder agreement search documents  browse documents site search agreements  contracts document title entire documentoptional governing lawoptional allalabamaalaskaarizonaarkansascaliforniacoloradoconnecticutdelawareflorida georgiahawaiiidahoillinoisindianaiowakansaskentuckylouisianamainemaryland massachusettsmichiganminnesotamississippimissourimontananebraskanevada new hampshirenew jerseynew mexiconew yorknorth carolinanorth dakotaohiooklahoma oregonpennsylvaniarhode islandsouth carolinasouth dakotatennesseetexasutah vermontvirginiawashingtonwest virginiawisconsinwyoming try our advanced search  clauses search contract clauses  browse contract clause library shareholder agreements these shareholder agreements are actual legal documents drafted by top law firms for their clients use them for competitive intelligence drafting documents or to get information about transactions within a particular industry or sector we have millions of legal documents and clauses that you can search for free  shareholders agreement by and among affinion group holdings inc and the stockholders as defined herein dated as of november  parties affinion group holdings inc  affinion group holdings inc document date  governing lawdelaware  stockholders agreementparties propetro holding corp  propetro holding corp law firm latham watkins document date  governing lawdelaware  lifevantage corporation  longterm incentive plan restricted stock grant agreementparties lifevantage corp  lifevantage corporation document date   rules of the astrazeneca global restricted stock plan adopted by the remuneration committee of the board of directors on  march  amended on  october  by the remuneration committee of the board of directors amended on  february  by the remuneration committee of the board of directorsparties astrazeneca plc document date   restricted stock unit agreement time based award grantedparties exa corp  exa corporation document date   lti restricted stock award agreement for  participant march  parties german american bancorp inc  german american bancorp inc document date   stockholders agreementparties presidio inc  ap viii aegis holdings lp  presidio inc document date  governing lawdelaware  amended and restated securityholders agreementparties presidio inc  aegis holdings inc  presidio inc law firm wachtell lipton document date  governing lawdelaware  samsung electronics completes acquisition of harmanparties harman international industries inc de  harman international industries incorporated  samsung electronics co ltd document date   stockholder rights agreementparties ecostim energy solutions inc  bienville argentina opportunities master fund lp  ecostim energy solutions inc  ft sof holdings vii llc  ft sof vii holdings llc law firm vinson elkinsstroock stroock document date  governing lawnew york  stockholders agreementparties ladder capital corp  joshua n korff pc  rref ii ladder llc law firm sullivan cromwellkirkland ellis document date  governing lawdelaware  amendment no  to stockholders agreementparties cj energy services inc  cj energy services inc  co solus alternative asset management  sola ltd  ultra master ltd law firm davis polkvinson elkins document date  governing lawdelaware  restricted stock unit issuance agreementparties iteris inc  interis inc  iteris inc document date  governing lawdelaware  second amendment to amended and restated stockholders agreementparties nacco industries inc  depository nacco industries inc document date   restricted stock award agreementparties d systems corp   three d systems  d systems corporation document date  governing lawdelaware  retention bonus pool restricted stock award agreement under the boston private financial holdings inc  inducement stock planparties boston private financial holdings inc  boston private financial holdings inc  nasdaq stock market inc document date  governing lawmassachusetts  form of employee restricted stock unit agreementparties univar inc  univar inc document date  governing lawdelaware  lithia motors inc restricted stock unit agreementparties lithia motors inc  lithia motors inc document date  governing laworegon  long term incentive restricted stock unit agreement pursuant to the john bean technologies corporation incentive compensation and stock plan director version  plan settle at separationparties john bean technologies corp  john bean technologies corporation document date  governing lawdelaware  lithia motors inc restricted stock unit agreement  performance and timevestingparties lithia motors inc  lithia motors inc document date  governing laworegon  restricted stock unit issuance agreementparties sjw group document date  governing lawcalifornia  covanta holding corporation restricted stock award agreementparties covanta holding corp  covanta energy corporation  covanta group  covanta holding corporation document date  governing lawdelaware  perkinelmer inc restricted stock agreement under  incentive planparties perkinelmer inc  perkinelmer inc law firm wilmer cutler document date  governing lawmassachusetts  principal shareholder agreementparties maxwell technologies inc  maxwell technologies inc  nesscap energy inc law firm dla piper document date  governing lawdelaware  restricted stock unit issuance agreementparties sjw group document date  governing lawcalifornia  perkinelmer inc restricted stock unit agreement under  incentive planparties perkinelmer inc  perkinelmer inc law firm wilmer cutler document date  governing lawmassachusetts  delek us holdings inc  longterm incentive plan performancebased restricted stock unit agreementparties delek us holdings inc  delek us holdings inc document date  governing lawdelaware  perkinelmer inc restricted stock unit agreement under  incentive planparties perkinelmer inc  perkinelmer inc law firm wilmer cutler document date  governing lawmassachusetts  form of restricted stock unit agreement pursuant to the linn energy inc  omnibus incentive planparties linn energy inc  linn energy inc document date  governing lawtexas  long term incentive restricted stock unit agreement pursuant to the john bean technologies corporation incentive compensation and stock plan director version  plan settle as vestsparties john bean technologies corp  john bean technologies corporation document date  governing lawdelaware  form of restricted stock unit agreement pursuant to the linn energy inc  omnibus incentive planparties linn energy inc  linn energy inc document date  governing lawtexas  valley national bancorp restricted stock award agreementparties valley national bancorp document date  governing lawnew jersey  perkinelmer inc restricted stock agreement under  incentive planparties perkinelmer inc  perkinelmer inc law firm wilmer cutler document date  governing lawmassachusetts  key manager restricted stock unit award agreement under the fmc corporation incentive compensation and stock planparties fmc corp  fmc corporation document date  governing lawdelaware  shareholders agreement dated  october  g between saudi aramco development company and nabors international netherlands bv relating to theparties nabors industries ltd  nabors international netherlands bv  onshore drilling joint venture  saudi aramco development company document date   restricted stock unit award agreementparties keycorp new document date   delek us holdings inc  longterm incentive plan restricted stock unit agreementparties delek us holdings inc  delek us holdings inc document date  governing lawdelaware  sarepta therapeutics inc  equity incentive plan restricted stock unit award agreementparties sarepta therapeutics inc  sarepta therapeutics inc document date  governing lawdelaware  restricted stock unit award agreement for nonemployee directors under the monogram residential trust inc second amended and restated incentive award planparties monogram residential trust inc  monogram residential trust inc document date   sarepta therapeutics inc amended and restated  equity incentive plan restricted stock agreementparties sarepta therapeutics inc  sarepta therapeutics inc document date  governing lawdelaware   omnibus incentive plan restricted stock unit agreementparties mcclatchy co  mcclatchy company document date  governing lawdelaware  advance auto parts inc  restricted stock unit award agreementparties advance auto parts inc  advance auto parts inc  vice president rewards and hr services document date   investor contactparties lattice semiconductor corp  brunswick group  canyon bridge merger sub inc  global ir partners  lattice semiconductor corporation  lattice canyon bridge acquisition company inc document date   lionbridge announces stockholder approval and closing of acquisition by hig capitalparties lionbridge technologies inc de  hig capital llc  lionbridge technologies inc law firm goodwin procterkirkland ellis document date    nonemployee director restricted stock agreementparties oceaneering international inc  oceaneering international inc document date  governing lawtexas  nu skin enterprises inc amended and restated  omnibus incentive plan performance restricted stock unit agreementparties nu skin enterprises inc document date   primerica inc employee restricted stock unit award agreementparties primerica inc  primerica inc document date  governing lawdelaware  axis capital holdings limited  longterm equity compensation plan employee restricted stock unit agreement time vesting stock settledparties axis capital holdings ltd  axis capital holdings limited  holding company document date    restricted stock unit agreementparties oceaneering international inc  oceaneering international inc document date  governing lawtexas  intl fcstone inc  restricted stock planparties intl fcstone inc  intl fcstone inc document date  governing lawdelaware browse by statego directly to a specific page of results tvm life science ventures vi lp formdscom  sec filings of fundraisings and investments in hedge funds private equity firms startups and growing companies formdscom newest filter local tvm life science ventures vi lp address po box  ugland house cayman island a  filings date filingtype reported sold incremental cash type exemptions link to raw filing  paper filing unknown unknown other sec link tvm capital life science announces initiation of investment operations of china biopharma capital i venture capital fund with first close of  million  tvm capital life science venture capital skip to primary navigation skip to content skip to footer tvm capital life science venture capitalinvesting in life science innovationmain navigation news · april   tvm capital life science announces initiation of investment operations of china biopharma capital i venture capital fund with first close of  million tvm capital life science to open new office in hong kong with dr mirko scherer as managing partner munichhong kong  april  tvm capital life science announced today that it has achieved the first closing of china biopharma capital i at us  million china biopharma capital i is a venture capital fund with subscription from chongqing lummy pharmaceutical co ltd a pharmaceutical company based in chongqing china which develops manufactures and markets pharmaceuticals and health care products lummy went public in  on the shenzhen stock market code  lummy operates six fully owned subsidiaries and employs more than  people with a strong focus on pharmaceutical innovation dr qiu yu chairman  president of lummy comments “the chinese pharmaceutical markets have experienced rapid growth over many years now general health awareness is on the rise resulting from sustainable overall economic growth combined with an aging society the chinese pharmaceutical market is becoming larger accordingly our mission is to provide this vibrant market with innovative exciting effective drugs and technology to improve human health we believe that continuous innovation is the only route to company growth currently innovations in pharmaceutical and medical technologies are mostly originated in north america and western europe with our commitment to china biopharma capital i lp we strive to introduce the world’s top medical services and medical technologies to the chinese market leveraging our understanding of the chinese pharmaceutical markets and our innovative operating model” china biopharma capital i will focus on investments in life science innovation in western companies with the objective to obtain licenses for development and commercialization in china the fund will capitalize on the substantial global footprint of tvm capital life science which invests into biopharmaceutical innovation from their seventh fund generation in europe the usa and canada and looks back on a successful  years track record in financing healthcare innovation dr hubert birner managing partner of tvm capital life science says “this new fund is an exciting opportunity to expand our reach into china and to leverage the unique deal flow and deal making capability of our venture capital teams in munich and montreal we are very happy to welcome mirko who will lead our efforts in china and we expect our investment team dedicated to china to grow substantially in the near future” dr mirko scherer is an experienced biotechnology executive and has led numerous financing and ma transactions in both public and private markets in europe and the us over  years dr scherer cofounded gpc biotech ag in  a former tvm capital life science portfolio firm – and served as its cfo over a decade mirko scherer comments on the fund’s objectives “the china biopharma capital i fund provides great opportunities to bridge the gap between the west and the east in the healthcare industry the china biopharma capital i fund provides an ideal vehicle to combine the expertise and the network of tvm capital life science in the west with the development regulatory and salesmarketing acumen of our chinese partner lummy we are looking forward to bringing many products and technologies to the greater china area together with our strategic investor lummy“ about tvm capital life science tvm capital life science is a group of independent investment advisories and fund managers the teams based in munich montreal and hong kong advise and manage venture capital funds for investments into innovative biotech pharmaceutical and medtech companies in europe canada the usa and asia the tvm capital life science practice arose from the life science investment practice within tvm capital gmbh munich one of the vc pioneers in biotech with a successful track record of  years in financing healthcare innovation the life science team looks back on more than  investments and over  exits in the last  years including more than  initial public offerings on all major us and european stock exchanges and combines longstanding international investment and company building experience with their track record of dedicated board work extensive global networks in the world of life science research and product development and a direct knowledge of the local markets tvm capital life science currently invests from its th fund generation tvm life science ventures vii with an integrated team of investment professionals fund generations iii to vi are managed by managing partners dr helmut m schühsler and dr hubert birner out of the munich office tvm lsv vii is advised by dr hubert birner and dr luc marengere out of munich and montreal wwwtvmcapitalcom or wwwtvmlifesciencecom about tvm capital group tvm capital is a group of globally acting venture capital and private equity firms with an operating track record of  years investment teams have financed more than  emerging companies across several industries since  during the last  years the firm has become increasingly specialized in the most attractive and highgrowth verticals in the broader healthcare markets with focus areas in financing innovative products and technologies in the european us and asian biopharmaceutical and medical device markets as well as healthcare services in the middle east and india tvm capital funds operate globally with dedicated life science venture capital funds advised by group members tvm life science management in montréal and in munich and its healthcare private equity fund managed by tvm capital healthcare partners out of dubai wwwtvmcapitalcom about lummy lummy pharmaceutical co ltd a pharmaceutical company based in chongqing china which develops manufactures and markets pharmaceuticals and health care products chonqing lummy went public in  on the shenzhen stock market code  lummy operates six fully owned subsidiaries and employs more than  people with a strong focus on pharmaceutical innovation for more information about lummy visit wwwcqlummycom tvm capital group tvm capital healthcare tvm capital life science tvm life science ventures vi lp opens position in albo  albireo pharma inc  fintelio tvm life science ventures vi lp opens position in albo  albireo pharma inc securityalbo  albireo pharma inc institutiontvm life science ventures vi lp shares ownership  related biod  biodel inc november    tvm life science ventures vi lp has filed a sc d form disclosing ownership of  shares of albireo pharma inc nasdaqalbo corresponding to  percent ownership  biodel inc has declared a standard industrial code sic of  which is the pharmaceutical preparations industry tvm life science ventures vimore info this page albo  albireo pharma incmore info tvm life science ventures vi lp ownership holdings in albireo pharma inc nasdaqalbo are shown in the following table dont miss an event create an alert dg filings this table shows a history of the dg filings made by the investor andor investor group note that the share values in this table are not directly comparable to any numbers shown in the f table if any filedateeffectivedateform prevshares reportedshares change in sharespercent ownershippercent change in ownershippercent   sc d   fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now cusip p iex realtime price become a power user join our private investing channel request membership amended statement of changes in beneficial ownership a support   newswire  home  log in boards stocks commodities forex cryptocurrency the lounge hot breakout boards ihub my stocks activity ticker buzz cloud most read most posted most followed members recent news active boards site stats new boards cannabis stocks tools data tools  charts trader alerts trades portfolio top lists price  news alerts commodities markets in d newswire more tools  newsletters my image gallery advanced search videos all news stock screener news filter live charts live news live desktop forex prices commodities etf center educational channel personal finance qa streamer level  follow feed quotechartlevel tradesnewsfinancialshistoricaltechnical analysismessage boardproteon therapeutics inc mm nasdaq amended statement of changes in beneficial ownership a date    pm source  edgar us regulatory stock  proteon therapeutics inc mm prto quote       pm amended statement of changes in beneficial ownership atweet print form    check this box if no longer subject to section  form  or form  obligations may continue see instruction b          united states securities and exchange commission washington dc  statement of changes in beneficial ownership of securities                                                                                    omb approval omb number  estimated average burden hours per response                         filed pursuant to section a of the securities exchange act of  or section h of the investment company act of                          name and address of reporting person  tvm life science ventures vi gmbh  co kg  issuer name and ticker or trading symbol proteon therapeutics inc  prto   relationship of reporting persons to issuer check all applicable  x  director                       x   owner  officer give title below       other specify below last          first          middle co tvm capital group ottostrasse   date of earliest transaction mmddyyyy  street munich m  city        state        zip  if amendment date original filed mmddyyyy    individual or jointgroup filing check applicable line  form filed by one reporting person  x  form filed by more than one reporting person table i  nonderivative securities acquired disposed of or beneficially owned title of security instr   trans date a deemed execution date if any  trans code instr   securities acquired a or disposed of d instr   and   amount of securities beneficially owned following reported transactions instr  and   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr  code v amount a or d price table ii  derivative securities beneficially owned  eg  puts calls warrants options convertible securities  title of derivate security instr   conversion or exercise price of derivative security  trans date a deemed execution date if any  trans code instr   number of derivative securities acquired a or disposed of d instr   and   date exercisable and expiration date  title and amount of securities underlying derivative security instr  and   price of derivative security instr   number of derivative securities beneficially owned following reported transactions instr   ownership form of derivative security direct d or indirect i instr   nature of indirect beneficial ownership instr  code v a d date exercisable expiration date title amount or number of shares series a convertible preferred stock            p                     common stock  par value             d     explanation of responses   this amendment to the original form  does not amend any item originally reported in table ii and the first line item of table ii is restated in this amendment for the sole purpose of gaining access to the electronic filing system footnotes relating to such first line item are included for completeness and have not been amended this amendment is made by the reporting persons solely to include the power of attorney attached hereto as exhibit    the shares are directly held by tvm life science ventures vi gmbh  co kg tvm vi hubert birner birner stefan fischer fischer and helmut schuhsler schuhsler are members of the investment committee of tvm life science management vi lp tvm vi management a special limited partner of tvm vi with voting and dispositive power over the shares held by tvm vi tvm vi management birner schuhsler and fischer each disclaim beneficial ownership of the shares held by tvm vi except to the extent of any pecuniary interest therein if any birner is a director of the issuer   the series a convertible preferred stock the series a stock is convertible at the option of the holder into proteon therapeutics inc common stock  par value per share the common stock at a price per share equal to    the series a stock has no expiration date   the certificate of designations for the series a stock contains a provision prohibiting conversion to the extent that upon conversion the holder together with its affiliates and any group members would beneficially own in excess of  of the number of shares of common stock then outstanding reporting owners reporting owner name  address relationships director  owner officer other tvm life science ventures vi gmbh  co kg co tvm capital group ottostrasse  munich m  x x tvm life science ventures vi lp co tvm capital group ottostrasse  munich m  x x birner hubert co tvm capital group ottostrasse  munich m  x x fischer stefan co tvm capital group ottostrasse  munich m  x schuhsler helmut co tvm capital group ottostrasse  munich m  x signatures s stefan fischer director of tvm life science ventures vi llc general partner of tvm life science ventures management vi lp managing limited partner of tvm life science ventures vi gmbh  co kg   signature of reporting person date s stefan fischer director of tvm life science ventures vi llc general partner of tvm life science ventures management vi lp managing limited partner of tvm life science ventures vi lp   signature of reporting person date s stefan fischer by power of attorney for hubert birner   signature of reporting person date s stefan fischer   signature of reporting person date s stefan fischer by power of attorney for helmut schuhsler   signature of reporting person date reminder report on a separate line for each class of securities beneficially owned directly or indirectly  if the form is filed by more than one reporting person see instruction bv  intentional misstatements or omissions of facts constitute federal criminal violations see  usc  and  usc ffa note file three copies of this form one of which must be manually signed if space is insufficient see instruction  for procedure persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb control number proteon therapeutics inc nasdaqprtohistorical stock chart  year  from jul  to jul  proteon therapeutics inc nasdaqprtointraday stock chart today  monday  july  latest prto messages view more posts remove from favorites add to favorites  message board see more message board posts your recent history lse gkp gulf keyst lse qpp quindell ftse ukx ftse  lse iof iofina fx gbpusd uk sterlin stocks youve viewed will appear in this box letting you easily return to quotes youve seen previouslyregister now to create your own custom streaming stock watchlist nyse amex and asx quotes are delayed by at least  minutesall other quotes are delayed by at least  minutes unless otherwise stated ex  exhhtm exhibit  exhibit    execution version   voting agreement   this voting agreement is made as of june   the “agreement” by and among proteon therapeutics inc a delaware corporation the “company” and tvm life science ventures vi lp the “stockholder” capitalized terms used in this agreement without definition shall have the respective meanings ascribed to such terms in the purchase agreement as defined below   w i t n e s s e t h   whereas contemporaneously with the execution and delivery of this agreement the company is entering into a a securities purchase agreement dated as of the date hereof as such agreement may hereafter be amended from time to time the “purchase agreement” with certain investors the “buyers” that provides for upon the terms and subject to the conditions set forth therein the sale by the company to the buyers of shares of the company’s series a convertible preferred stock par value  the “preferred stock” and b voting agreements dated as of the date hereof together with this agreement each a “voting agreement” and collectively the “voting agreements” with certain of the company’s other stockholders which voting agreements contain substantially the same terms as those contained herein and   whereas pursuant to the purchase agreement the company has agreed to call a meeting of its stockholders for the purpose of seeking approval of the company’s stockholders for a the sale and issuance by the company of an aggregate of  shares of preferred stock the “preferred shares” to the buyers pursuant to and in accordance with the terms of the purchase agreement and b the issuance of shares of the company’s common stock par value  per share the “common stock” upon conversion of such preferred stock in accordance with the terms of the certificate of designation which approval is required to satisfy the applicable requirements of the nasdaq stock market the “proposal”   whereas as of the date hereof the stockholder beneficially owns the number of shares of common stock set forth opposite the stockholder’s name on schedule i hereto all such shares so beneficially owned and which may hereafter be acquired by such stockholder prior to the termination of this agreement whether upon the exercise of options conversion of convertible securities exercise of warrants or by means of purchase dividend distribution or otherwise being referred to herein as the “shares” and   whereas in order to induce the company and the buyers to enter into the purchase agreement the stockholder is willing to enter into this agreement   now therefore in consideration of the foregoing and the mutual covenants and agreements herein contained and intending to be legally bound hereby the company and the stockholder hereby agree as follows         article i   transfer and voting of shares and other covenants of the stockholder   section  voting of shares from the date hereof until termination of this agreement pursuant to section  hereof the “term” at any meeting of the stockholders of the company however called and at any adjournment or postponement thereof and in any action by written consent of the stockholders of the company in either case at or pursuant to which the proposal is to be considered and voted on by the stockholders of the company the stockholder shall a appear at such meeting or otherwise cause the shares to be counted as present thereat for purposes of establishing a quorum and b vote or cause to be voted the shares i in favor of the proposal and such other matters as may be necessary or advisable to consummate the transactions contemplated by the purchase agreement the “transactions” and ii against the approval or adoption of any proposal made in opposition to or in competition with the proposal or the transactions and against any other action that is intended or could reasonably be expected to otherwise materially impede interfere with delay postpone discourage or adversely affect the consummation of the transactions if the stockholder is the beneficial owner but not the record holder of any of the shares the stockholder agrees to cause the record holder and any nominees to vote all of such shares in accordance with this section  including by executing such documentation as shall be requested by the record holder or any such nominee for purposes of giving voting instructions thereto   section  grant of irrevocable proxy   a                the stockholder hereby irrevocably and unconditionally to the fullest extent permitted by law grants to and appoints the company and each of its executive officers and any of them in their capacities as officers of the company the “grantees” as the stockholder’s proxy and attorneyinfact with full power of substitution and resubstitution for and in the name place and stead of the stockholder to vote the shares to instruct nominees or record holders to vote the shares or to grant a consent or approval or dissent or disapproval in respect of the shares in each case in accordance with section  hereof and in the discretion of the grantees with respect to any proposed adjournments or postponements of any meeting of stockholders of the company at which any of the matters described in section  hereof are to be considered   b               the stockholder hereby affirms that the irrevocable proxy set forth in this section  is given in connection with the execution of the purchase agreement and the proposed issuance of the preferred shares as contemplated thereby and that such irrevocable proxy is given to secure the performance of the duties of the stockholder under this agreement the stockholder hereby further affirms that the irrevocable proxy is coupled with an interest and may under no circumstances be revoked except as otherwise set forth herein the stockholder hereby ratifies and confirms all that the grantees may lawfully do or cause to be done by virtue hereof the irrevocable proxy set forth in this section  is executed and intended to be irrevocable in accordance with the provisions of section  of the delaware general corporation law notwithstanding this section  the proxy granted by the stockholder shall be revoked upon termination of this agreement in accordance with its terms         c                the grantees may not exercise this irrevocable proxy on any other matter except as provided above   section  no inconsistent arrangements except as contemplated by this agreement from the date hereof until the record date for the company stockholders meeting the stockholder will not a directly or indirectly sell transfer assign pledge hypothecate tender encumber or otherwise dispose of in any manner any of the shares or consent or agree to do any of the foregoing b directly or indirectly limit its right to vote in any manner any of the shares other than as set forth in this agreement including without limitation by the grant of any proxy power of attorney or other authorization in or with respect to the shares other than any such proxy power of attorney or other authorization consistent with and for purposes of complying with the provisions of section  hereof by depositing the shares into a voting trust or by entering into a voting agreement or consent or agree to do any of the foregoing or c take any action which would have the effect of preventing or disabling the stockholder from performing its obligations under this agreement notwithstanding the foregoing the stockholder may sell or transfer any or all of the shares to any person in a private transaction at any time on or prior to the record date for the company stockholders meeting provided that the transferee of such shares executes and delivers to the company a voting agreement with respect to such transferred shares containing substantially the same terms as this agreement for purposes of this section  the term “sell” or “transfer” or any derivatives thereof shall include but not be limited to a a sale transfer or disposition of record or beneficial ownership or both and b a short sale with respect to the shares or substantially identical property entering into or acquiring an offsetting derivative contract with respect to the shares or substantially identical property entering into or acquiring a futures or forward contract to deliver the shares or substantially identical property or entering into any transaction that has the same effect as any of the foregoing   section  stop transfer the company shall issue stoptransfer instructions to the transfer agent for the shares instructing the transfer agent not to register any transfer of shares during the term except in compliance with the terms of this agreement   section  additional shares the stockholder hereby agrees that while this agreement is in effect the stockholder shall promptly notify the company of any new shares acquired whether upon the exercise of options conversion of convertible securities exercise of warrants or by means of purchase dividend distribution or otherwise by such stockholder after the date hereof   section  disclosure the stockholder hereby authorizes the company to publish and disclose in any announcement or disclosure required by the united states securities and exchange commission the “sec” including in any proxy statement filed with the sec in connection with any meeting of stockholders of the company at which the proposal is to be considered and all documents and schedules filed with the sec in connection with the foregoing the stockholder’s identity and ownership of the shares and the nature of the stockholder’s commitments arrangements and understandings under this agreement         article ii   representations and warranties of the stockholder   the stockholder hereby represents and warrants to the company as of the date hereof and as of the date of any stockholder meeting at which the proposal is considered including any adjournment or postponement thereof or the date of the taking of any action by written consent with respect to the proposal as follows   section  due authorization etc the stockholder has all requisite power and authority to execute deliver and perform this agreement and to take the actions contemplated hereby including the granting of the irrevocable proxy pursuant to section  hereof all of which have been duly authorized by all action necessary on the part of the stockholder the execution delivery and performance of this agreement and the consummation of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the stockholder this agreement has been duly executed and delivered by or on behalf of the stockholder and constitutes a legal valid and binding obligation of the stockholder enforceable against the stockholder in accordance with its terms except as enforcement may be limited by bankruptcy insolvency moratorium or other similar laws and except that the availability of equitable remedies including specific performance is subject to the discretion of the court before which any proceeding for such remedy may be brought   section  no violation neither the execution and delivery of this agreement nor the performance of this agreement by the stockholder will a require the stockholder to file or register with or obtain any material permit authorization consent or approval of any governmental agency authority administrative or regulatory body court or other tribunal foreign or domestic or any other entity or b violate or cause a breach of or default under or conflict with any contract agreement or understanding any statute or law or any judgment decree order regulation or rule of any governmental agency authority administrative or regulatory body court or other tribunal foreign or domestic or any other entity or any arbitration award binding upon the stockholder except for such violations breaches defaults or conflicts which would not individually or in the aggregate be reasonably likely to impair or have an adverse effect on the stockholder’s ability to satisfy its obligations under this agreement or render inaccurate any of the other representations made by the stockholder in this agreement no proceedings are pending which if adversely determined will have an adverse effect on the stockholder’s ability to vote any of the shares   section  ownership of shares the stockholder has good and marketable title to and is the sole legal and beneficial owner determined in accordance with rule d under the securities exchange act of  as amended the “exchange act” of the shares set forth opposite its name on schedule i hereto in each case free and clear of all liabilities claims liens options security interests proxies voting trusts voting agreements charges participations and encumbrances of any kind or character whatsoever except as may be imposed by federal state or foreign securities laws and this agreement the stockholder has not previously assigned or sold any of the shares to any third party on the date hereof the shares set forth opposite the stockholder’s name on schedule i hereto constitute all of the shares owned of record or beneficially by the stockholder the stockholder has sole voting power and sole power of disposition with respect to the shares with no restrictions on its voting rights or rights of disposition pertaining thereto         section  voting authority the stockholder has full legal power authority and right to vote all of the shares owned of record andor beneficially by the stockholder in favor of the proposal and the approval and authorization of the transactions without the consent or approval of or any other action on the part of any other person without limiting the generality of the foregoing the stockholder has not entered into any voting agreement other than this agreement with any person with respect to any of the shares granted any person any proxy revocable or irrevocable or power of attorney with respect to any of the shares deposited any of the shares in a voting trust or entered into any arrangement or agreement with any person limiting or affecting stockholder’s legal power authority or right to vote the shares on any matter for purpose hereof “person” means any individual corporation limited or general partnership limited liability company limited liability partnership trust association joint venture governmental entity or any other entity or group as such term is defined in section d of the exchange act   section  reliance by the company the stockholder understands and acknowledges that the company is entering into the purchase agreement in reliance upon the stockholder’s execution and delivery of this agreement and the representations and warranties of the stockholder contained herein   article iii   miscellaneous   section  termination this agreement shall terminate and be of no further force and effect upon the earliest of i immediately following a meeting of the company’s stockholders at which the proposal is voted upon and approved by the company’s stockholders which meeting is duly called and held for such purpose and at which a quorum was present and acting throughout and ii the termination of the purchase agreement at any time prior to the consummation of the closing contemplated under the purchase agreement no such termination of this agreement shall relieve any party hereto from any liability for any breach of this agreement prior to such termination   section  further assurances from time to time at the request of the company and without further consideration the stockholder will execute and deliver to the company such documents and take such action as the company may reasonably deem to be necessary or desirable to carry out the provisions hereof   section  no waiver the failure of any party hereto to exercise any right power or remedy provided under this agreement or otherwise available in respect hereof at law or in equity or to insist upon compliance by any other party hereto with its obligations hereunder or any custom or practice of the parties at variance with the terms hereof shall not constitute a waiver by such party of its right to exercise any such or other right power or remedy or to demand such compliance         section  specific performance the stockholder acknowledges that the company will be irreparably harmed and that there will be no adequate remedy at law for a violation of any of the covenants or agreements of the stockholder that are contained in this agreement it is accordingly agreed that in addition to any other remedies which may be available to the company upon the breach by the stockholder of such covenants and agreements the company will have the right without the posting of a bond or other security to obtain injunctive relief to restrain any breach or threatened breach of such covenants or agreements or otherwise to obtain specific performance of any of such covenants or agreements accordingly should the company institute an action or proceeding seeking specific enforcement of the provisions hereof the stockholder hereby waives the claim or defense that the company has an adequate remedy at law and hereby agrees not to assert in any such action or proceeding the claim or defense that such a remedy at law exists   section  notice any notices consents waivers or other communications required or permitted to be given under the terms of this agreement must be in writing and will be deemed to have been delivered a upon receipt when delivered personally b upon receipt when sent by facsimile except notice may not be delivered to the company via facsimile or email provided confirmation of transmission is mechanically or electronically generated and in the case of an email a read receipt is received and in each case kept on file by the sending party or c upon receipt when delivered by a nationally recognized overnight delivery service in each case properly addressed to the party to receive the same the addresses and facsimile numbers for such communications shall be   i       if to the company to   proteon therapeutics inc  west street waltham massachusetts  attention chief executive officer email seriesaproteontxcom   with a copy to   morgan lewis  bockius llp one federal street boston massachusetts  attn julio e vega esq fax no   email juliovegamorganlewiscom   ii       if to the stockholder as set forth in schedule i hereto         section  capacity notwithstanding anything in this agreement to the contrary the stockholder makes no agreement or understanding herein in any capacity other than in the stockholder’s capacity as a record holder and beneficial owner of the shares   section  expenses each of the parties hereto will pay its own expenses incurred in connection with this agreement   section  headings the headings contained in this agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this agreement   section  severability if any term or other provision of this agreement is invalid illegal or incapable of being enforced by any rule of law or public policy all other conditions and provisions of this agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner adverse to any party upon such determination that any term or other provision is invalid illegal or incapable of being enforced the parties hereto shall negotiate in good faith to modify this agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that obligations hereunder are fulfilled to the maximum extent possible   section  entire agreement this agreement constitutes the entire agreement and supersedes any and all other prior agreements and undertakings both written and oral among the parties or any of them with respect to the subject matter hereof   section  successors and assigns except as otherwise expressly provided herein this agreement shall inure to the benefit of and be binding upon the successors assigns heirs executors administrators and permitted assigns of the parties hereto no assignment or delegation by any party to this agreement of any obligations of such party under this agreement shall operate to relieve or release such party from such obligations or from any liability hereunder for failure of such obligations to be performed in accordance with their respective terms   section  governing law consent to jurisdiction waiver of jury trial this agreement will be governed by and construed and enforced in accordance with the laws of the state of delaware without regard to its principles of conflicts of laws each party hereby irrevocably submits to the nonexclusive jurisdiction of the state and federal courts sitting in delaware for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein including with respect to the enforcement of this agreement and hereby irrevocably waives and agrees not to assert in any suit action or proceeding any claim that it is not personally subject to the jurisdiction of any such court that such suit action or proceeding is improper or is an inconvenient venue for such proceeding each party hereby irrevocably waives personal service of process and consents to process being served in any such suit action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery with evidence of delivery to such party at the address in effect for notices to it under this agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law each of the parties hereto waives any right to request a trial by jury in any litigation with respect to this agreement and represents that counsel has been consulted specifically as to this waiver         section  amendment this agreement may not be amended except by an instrument in writing signed on behalf of the company and the stockholder if any material amendment or waiver is proposed to be made with respect to any other voting agreement the company hereby covenants and agrees that the stockholder shall be afforded the opportunity to enter into or receive as applicable a comparable amendment or waiver with respect to this agreement   section  remedies not exclusive all rights powers and remedies provided under this agreement or otherwise available in respect hereof at law or in equity will be cumulative and not alternative and the exercise of any thereof by any party will not preclude the simultaneous or later exercise of any other such right power or remedy by such party   section  counterparts this agreement may be executed in two or more counterparts each of which shall constitute an original but all of which when taken together shall constitute but one instrument and shall become effective when one or more counterparts have been signed by each party hereto and delivered to the other parties in the event that any signature is delivered by facsimile transmission or by email delivery of a “pdf” format data file such signature shall create a valid and binding obligation of the party executing or on whose behalf such signature is executed the same with the same force and effect as if such facsimile or “pdf” signature were the original thereof   remainder of this page intentionally left blank         in witness whereof the parties hereto have caused this agreement to be executed as of the date first written above     proteon therapeutics inc         by s timothy noyes     name timothy noyes     title president and chief executive officer         signature page to voting agreement       name of stockholder       tvm life science ventures vi lp         by its general partner tvm life science ventures vi cayman ltd               by s josef moosholzer     name josef moosholzer     title authorized officer       by s stefan fischer     name stefan fischer     title authorized officer         signature page to voting agreement     schedule i   name of stockholder   number of shares beneficially owned       tvm life science ventures vi lp  arlington street suite  boston ma      telephone no       facsimile no        email address fischertvmcapitalcom                      court of chancery explains categories of damages delaware business litigation report delaware business litigation report home about our attorneys contact about this blogsummaries and analysis of recent delaware court decisions concerning businessrelated litigation stay connected subscribe to this blog via rss youtube join us on linkedin follow us on twitter subscribe by email topics articlescase summariesappraisalarbitrationbooks and recordsbreach of contractbusiness insurancebusiness tortsclass actionscontrolling stockholdercorporate chartersderivative claimsdirectorsdiscoverydissolutionelectronic discoveryfiduciary dutyinjunctionsintellectual propertyinterim fee applicationsjurisdictionllc agreementslp agreementsmasecuritiesspecial committeesstockholder liststockholders meetingssuperior courttoxic tortsnewspodcastresourcesuncategorized archives  july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january  december november october september august july june may april march february january morris james blogs delaware business bankruptcy report delaware ediscovery report delaware healthcare industry blog links aba section of business law court of chancery delaware state bar association superior court supreme court of delaware united states district court district of delaware court of chancery explains categories of damages by edward m mcnally on february   posted in ma pharmaceutical product development inc v tvm life science ventures vi lp  ca vcs february   agreements sometimes try to limit any damages from a misrepresentation or contract breach by excluding consequential or special damages  this decision notes that is hard to do because what falls into what category of damages is not always clear  better to limit damages some other way such as by the amount paid to the seller the opinion is also noteworthy as an example of the farreaching scholarship the court undertook to understand the science involved in the dispute  litigants should not underestimate the court of chancery in such matters like email linkedin tags ma privacy policy disclaimer site by firmseek   morris james llp all rights reserved delaware business litigation report morris james llp  rehoboth avenue rehoboth beach de  stay connected subscribe to this blog via rss youtube join us on linkedin follow us on twitter subscribe by email